Soleno Therapeutics (SLNO) had the highest return between June 1, 2022 and December 31, 2023 by a US stock with a market cap of $2B+, returning 1,433.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 6/1/2022 - 12/31/2023 | 1,433.33% |
Rhythm Pharmaceuticals (RYTM) | 6/1/2022 - 12/31/2023 | 1,220.98% |
Immunovant (IMVT) | 6/1/2022 - 12/31/2023 | 895.98% |
MoonLake Immunotherapeutics (MLTX) | 6/1/2022 - 12/31/2023 | 800% |
Viking Therapeutics (VKTX) | 6/1/2022 - 12/31/2023 | 727.11% |
Nuvalent (NUVL) | 6/1/2022 - 12/31/2023 | 726.85% |
QXO (QXO) | 6/1/2022 - 12/31/2023 | 518.92% |
BridgeBio Pharma (BBIO) | 6/1/2022 - 12/31/2023 | 486.77% |
Super Micro Computer (SMCI) | 6/1/2022 - 12/31/2023 | 462% |
New Oriental Education & Technology (EDU) | 6/1/2022 - 12/31/2023 | 459.39% |
ELF Beauty (ELF) | 6/1/2022 - 12/31/2023 | 442.43% |
Symbotic (SYM) | 6/1/2022 - 12/31/2023 | 439.75% |
Modine Manufacturing (MOD) | 6/1/2022 - 12/31/2023 | 400% |
F&G Annuities & Life (FG) | 6/1/2022 - 12/31/2023 | 374.45% |
Arcellx (ACLX) | 6/1/2022 - 12/31/2023 | 364.82% |
Vertiv (VRT) | 6/1/2022 - 12/31/2023 | 340.42% |
Verona Pharma PLC ADR (VRNA) | 6/1/2022 - 12/31/2023 | 338.85% |
Abercrombie & Fitch (ANF) | 6/1/2022 - 12/31/2023 | 325.16% |
TG Therapeutics (TGTX) | 6/1/2022 - 12/31/2023 | 293.55% |
Miniso Group Holding (MNSO) | 6/1/2022 - 12/31/2023 | 286.22% |
YPF Sociedad Anonima (YPF) | 6/1/2022 - 12/31/2023 | 281.15% |
Scholar Rock (SRRK) | 6/1/2022 - 12/31/2023 | 273.02% |
89bio (ETNB) | 6/1/2022 - 12/31/2023 | 266.23% |
Sterling Construction (STRL) | 6/1/2022 - 12/31/2023 | 253.99% |
Madrigal Pharmaceuticals (MDGL) | 6/1/2022 - 12/31/2023 | 247.68% |
